Clinical trials
Dementia clinical trials
Below are recruiting dementia clinical trials, each written for real people, not researchers. We’re tracking 488 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07284264Recruiting
Early Alzheimer's detection study using digital tools
This study uses a digital tool to help detect early signs of Alzheimer's disease in people aged 50 and older. It aims to find high-risk individuals who may benefit from early monitoring.
BeijingAges 50 years+ - NCT06885918Recruiting
ALS Research Collaborative study
This study is a research collaborative that collects information from people with ALS or their families. It aims to better understand the disease and find markers that could help develop treatments.
Watertown, MassachusettsAges 18 years+ - NCT06889818Recruiting
Alzheimer's treatment and diagnostics registry study
This study creates a registry for people who are using newly approved Alzheimer's medications. It tracks how these treatments work over time and may help researchers learn more about diagnosing and treating Alzheimer's.
IncheonAges 19 years+ - NCT07272811Recruiting
Computer memory testing for early Alzheimer's signs
This study uses a computer-based platform to test memory and thinking in healthy adults and in people with mild memory concerns (called aMCI). The goal is to better understand how memory changes with age and to spot early signs of Alzheimer's disease.
Milan, ItalyAges 55–80 - NCT07259499Recruiting
Predictors of emergency visits in frail older adults
This study looks at why frail older adults go to the emergency room. Researchers want to see if blood tests and brain scans can help predict who needs emergency care. Participation involves one interview and having had a recent brain scan and blood work.
Pisa, PisaAges 65 years+ - NCT06068361Recruiting
Better diagnosis of Lewy body dementia
This study uses a combination of tests to improve diagnosis of dementia with Lewy bodies compared to Alzheimer's disease and healthy aging. You may help doctors identify the right diagnosis more accurately.
Paris, FranceAges 55–85 - NCT07250113Enrolling by invitation
WeCareToFeedDysphagia study for care partners of older adults
This trial tests a program to help care partners of older adults with Alzheimer's disease and swallowing problems. It aims to reduce stress and improve care at home.
Manhasset, New YorkAges 18 years+ - NCT07237009Recruiting
Personalized reminiscence therapy for memory loss
This trial tests a digital app that uses personal photos and memories to help people with early memory problems feel less depressed or apathetic. It's designed for seniors who have mild cognitive impairment or early dementia.
AngersAges 60 years+ - NCT07235111Recruiting
Studying biomarkers for neurodegenerative diseases
This study is looking for people with neurodegenerative diseases (like Alzheimer's, Parkinson's, ALS) to help researchers find new markers in the body that could help understand these conditions better and possibly lead to better treatments.
Genoa, GenoaAges 18 years+ - NCT07234851Enrolling by invitation
Brain tissue study of synaptic loss in mental and brain diseases
This study looks at how brain connections break down in people with psychiatric disorders (like schizophrenia, depression, or bipolar disorder) or neurodegenerative diseases (like Alzheimer's or frontotemporal dementia). It uses donated brain tissue after death to understand why symptoms occur.
BarcelonaAges 40 years+ - NCT07222449Enrolling by invitation
Wearable devices and blood tests for sleep in Alzheimer's
This study uses wrist monitors and blood tests to understand sleep problems in people with Alzheimer's dementia. It aims to improve sleep management through digital therapy and personalized insights.
Beigang, YunlinAges Any age - NCT06263920Recruiting
Study on late-onset epilepsy and its links
This study looks at people who had their first seizure or were diagnosed with epilepsy after age 18, and compares them to people with migraine. The goal is to understand what might be connected to epilepsy that starts later in life.
Preston, LancashireAges 18 years+ - NCT07216716Recruiting
Health app recommendation tool for Alzheimer's caregivers
This study tests a tool that helps find health apps for people caring for a loved one with Alzheimer's or a related dementia. It aims to see if the tool makes it easier to choose useful apps for your caregiving journey.
Pittsburgh, PennsylvaniaAges 18–65 - NCT07219680Recruiting
Communication quality of life in primary progressive aphasia
This trial tests a therapy to improve communication for people with primary progressive aphasia (PPA), a condition that slowly affects language. You and a care partner will attend video sessions to work on communication goals together.
Austin, TexasAges 40 years+ - NCT07218081RecruitingPhase 1
Intermittent deep brain stimulation for early Alzheimer's
This trial tests a treatment that sends gentle electrical pulses to a part of the brain involved in memory and thinking. It is for people with early-stage Alzheimer's who live at home and have a caregiver who can help.
Augusta, GeorgiaAges 65–85 - NCT05460143Recruiting
Optical brain scanning to study memory and thinking
This study uses brain “optical” and possibly MRI scans to understand how thinking and memory work in people with Lewy body dementia, Alzheimer’s disease, or mild memory problems. It may help researchers find better ways to measure brain changes and cognition over time.
CambridgeAges 18 years+ - NCT06933667Recruiting
Brain health and wellness study for adults 50+
This study looks at brain health and wellness programs for people aged 50 and older. It may help you stay mentally sharp and active.
Toronto, OntarioAges 50 years+ - NCT07182019Recruiting
Connecting families to fight loneliness in dementia
This study tests a program that helps people with dementia and their loved ones stay in touch through video calls. It aims to reduce social isolation and improve well-being.
Edmonton, AlbertaAges 65 years+ - NCT06949865Recruiting
AI-enhanced levodopa challenge test for parkinsonism
This study uses artificial intelligence (AI) to improve a standard test for parkinsonism called the levodopa challenge test. It may help doctors better understand how your movement symptoms respond to levodopa, a common Parkinson's medication.
BeijingAges 50–75 - NCT07154394Recruiting
Heart amyloid and function in Alzheimer's disease
This study examines whether amyloid plaques in the heart affect heart function in people with Alzheimer's disease. It uses brain amyloid PET and MRI scans to explore a potential link.
Essen, North Rhine-WestphaliaAges 18 years+ - NCT07154511RecruitingPhase 1/Phase 2
Tributyrin for Parkinson's with memory problems
This trial tests a supplement called tributyrin to see if it can help with thinking and memory problems in people with Parkinson's disease. You may be able to join if you have both Parkinson's and mild cognitive impairment or dementia.
Ann Arbor, MichiganAges 45 years+ - NCT07140601Recruiting
Environmental pollutants and brain health study
This study looks at how environmental pollutants might affect brain health and neurological disorders. If you join, you will help researchers understand possible links between pollution and conditions like Parkinson's or Alzheimer's.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07143734RecruitingPhase 2
Brain stimulation for early Alzheimer's disease
This study tests a new, noninvasive brain stimulation method called Transcranial Pulse Stimulation (TPS) for people in the early stages of Alzheimer's disease. The goal is to see if it can help improve symptoms.
Hong KongAges 60–90 - NCT07120347Recruiting
Remote sensors to study daily activities in older adults with mild memory loss
This study uses remote sensors (like motion detectors) to see how older adults with mild memory or thinking problems go about their daily lives. It may help researchers learn how to better support people with early dementia.
Columbia, MissouriAges 50 years+
Hear when a new Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for dementia?
- Yes. Clin2 currently lists 488 recruiting dementia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a dementia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a dementia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.